Oral cancer is one of the largest group of cancers, which comes under category of Head and Neck cancer. It includes lips, tongue, throat, sinuses, and floor of the mouth.
Due to the COVID-19 pandemic, the global Oral Cancer Rapid Test Kit market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Oral Cancer Rapid Test Kit market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage is %, and it is predicted that China market share will reach % in 2030, trailing a CAGR of % through the analysis period. As for the Europe Oral Cancer Rapid Test Kit landscape, Germany is projected to reach US$ million by 2030. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
North America is expected to hold relatively high market share due to factors such as growing awareness about the disease and rise in the aging population. However, Asia Pacific region and European regions also might have good market due to increase in incidence of oral cancer.
This report focuses on Oral Cancer Rapid Test Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Oral Cancer Rapid Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Oral Cancer Rapid Test Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
OncAlert Oral Cancer LAB
Lab on Chip
Insilixa Test
Prevo-Check
Segment by Application
Hospitals
Diagnostic Centers
Research Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
BD
Abbott
Bio-Rad
ThermoFisher
Beckman Coulter
WanTai BioPharm
Trinity Biotech
